Association study between keratinocyte-derived growth factor gene polymorphisms and susceptibility to vitiligo vulgaris in a Taiwanese population: potential involvement of stem cell factor
C-C.E. Lan
Department of Dermatology, Kaohsiung Medical University Hospital; Department of Dermatology, College of Medicine; Center of Excellence for Environmental Medicine; Kaohsiung Medical University, Kaohsiung, Taiwan
Search for more papers by this authorY-C. Ko
Department of Public Health, Faculty of Medicine, College of Medicine
Search for more papers by this authorH-P. Tu
Department of Public Health, Faculty of Medicine, College of Medicine
Graduate Institute of Medicine, College of Medicine
Search for more papers by this authorC-H. Lee
Faculty of Public Health, Kaohsiung Medical University, Kaohsiung, Taiwan
Search for more papers by this authorC-S. Wu
Department of Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
Search for more papers by this authorH-S. Yu
Department of Dermatology, Kaohsiung Medical University Hospital; Department of Dermatology, College of Medicine; Center of Excellence for Environmental Medicine; Kaohsiung Medical University, Kaohsiung, Taiwan
Search for more papers by this authorC-C.E. Lan
Department of Dermatology, Kaohsiung Medical University Hospital; Department of Dermatology, College of Medicine; Center of Excellence for Environmental Medicine; Kaohsiung Medical University, Kaohsiung, Taiwan
Search for more papers by this authorY-C. Ko
Department of Public Health, Faculty of Medicine, College of Medicine
Search for more papers by this authorH-P. Tu
Department of Public Health, Faculty of Medicine, College of Medicine
Graduate Institute of Medicine, College of Medicine
Search for more papers by this authorC-H. Lee
Faculty of Public Health, Kaohsiung Medical University, Kaohsiung, Taiwan
Search for more papers by this authorC-S. Wu
Department of Dermatology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
Search for more papers by this authorH-S. Yu
Department of Dermatology, Kaohsiung Medical University Hospital; Department of Dermatology, College of Medicine; Center of Excellence for Environmental Medicine; Kaohsiung Medical University, Kaohsiung, Taiwan
Search for more papers by this authorConflicts of interestNone declared.
Summary
Background Vitiligo vulgaris is a depigmentary disorder resulting from the disappearance of functional melanocytes. Currently, the pathogenesis of this disorder remains obscure.
Objectives Genetic analysis of patients with vitilgo may provide important clues for elucidating the complex pathomechanisms involved in the disease process. Because dysfunctional keratinocytes have recently been implicated in the pathogenesis of vitiligo vulgaris, we conducted a case–control association study to investigate this phenomenon.
Patients and methods Fifty-one patients with vitiligo vulgaris and 118 healthy controls from Taiwan were recruited to investigate the association between relevant keratinocyte-related genes and the occurrence of vitiligo vulgaris. This study genotyped 11 single-nucleotide polymorphisms (SNPs) in five genes including stem cell factor (SCF, also known as KITLG), basic fibroblast growth factor (bFGF, also known as NuDT6), endothelin-1 (EDN1), hepatocyte growth factor (HGF) and stem cell growth factor (SCGF, also known as CLEC11A).
Results Our results revealed that the A allele for SNP rs11104947 in the SCF gene and the T allele for SNP rs13866 in the SCGF gene were, respectively, associated with a 1·95- and a 2·14-fold risk of developing vitiligo vulgaris. A higher risk was also detected among subjects who carried the SCF rs995029/rs11104947 C/A haplotype (odds ratio = 2·45). Furthermore, the at-risk alleles for SCF rs11104947 (A allele) and for SCGF SNP rs13866 (T allele) were found to display a 7·92-fold increased gene–gene combined risk. No significant relationship between polymorphic frequency for genes bFGF, EDN1 as well as HGF and occurrence of vitiligo vulgaris was observed.
Conclusions These novel genetic findings provide new insights in relation to the mechanisms that might be involved in the development of vitiligo vulgaris.
References
- 1 Lerner AB. Vitiligo. J Invest Dermatol 1959; 32: 285–310.
- 2 Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113: 47–52.
- 3 Schmid-Ott G, Künsebeck HW, Jecht E et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol 2007; 21: 456–61.
- 4 Taieb A. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res 2000; 13: 41–7.
- 5 Hann SK, Nordlund JJ. Clinical features of generalized vitiligo. In: Vitiligo ( SK Hann, JJ Nordlund, eds). Oxford: Blackwell Science, 2000; 35–48.
- 6 Alkhateeb A, Fain PR, Thody A et al. Epidemiology of vitiligo and associated autoimmune disease in Caucasian probands and their families. Pigment Cell Res 2003; 16: 208–14.
- 7 Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 1994; 55: 981–90.
- 8 Majumder PP, Das SK, Li CC. A genetic model for vitiligo. Am J Hum Genet 1988; 43: 119–25.
- 9 Das SK, Majumder PP, Majumdar TK, Haldar B. Studies on vitiligo. II. Familial aggregation and genetics. Genet Epidemiol 1985; 2: 255–62.
- 10 Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol 1993; 129: 994–8.
- 11 Zhang XJ, Liu HS, Liang YH et al. Association of HLA class I alleles with vitiligo in Chinese Hans. J Dermatol Sci 2004; 35: 165–8.
- 12 Zamani M, Spaepen M, Sghar SS et al. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 2001; 145: 90–4.
- 13 Casp CB, She JX, McCormack WT. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002; 15: 62–6.
- 14 Casp CB, She JX, McCormack WT. Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun 2003; 4: 492–9.
- 15 Kemp EH, Ajjan RA, Waterman EA et al. Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo. Br J Dermatol 1999; 140: 73–8.
- 16 Jin SY, Park HH, Li GZ et al. Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res 2004; 17: 84–6.
- 17 Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB. Biology of melanocytes. In: Dermatology in General Medicine ( IM Freeberg, AZ Eisen, K Wolff, KF Austen, LA Goldsmith, SI Katz, TB Fitzpatrick, eds), 5th edn. New York: McGraw-Hill, 1999; 5.
- 18 Lee AY, Youm YH, Kim NH et al. Keratinocytes in the depigmented epidermis of vitiligo are more vulnerable to trauma (suction) than keratinocytes in the normally pigmented epidermis, resulting in their apoptosis. Br J Dermatol 2004; 151: 995–1003.
- 19 Bondanza S, Maurelli R, Paterna P et al. Keratinocyte cultures from involved skin in vitiligo patients show an impaired in vitro behavior. Pigment Cell Res 2007; 20: 288–300.
- 20 Lee AY, Kim NH, Choi WI, Youm YH. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo. J Invest Dermatol 2005; 124: 976–83.
- 21 Moretti S, Spallanzani A, Amato L et al. Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines. Arch Dermatol 2002; 138: 273–4.
- 22
Benjamini Y,
Hochberg Y.
Controlling the false discovery rate: a practical and powerful approach to multiple testing.
J Roy Stat Soc Ser B
1995; 57: 289–300.
10.1111/j.2517-6161.1995.tb02031.x Google Scholar
- 23 Halaban R, Rubin JS, Funasaka Y et al. Met and heptocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 1992; 7: 2195–206.
- 24 Halaban R. The regulation of normal melanocyte proliferation. Pig Cell Res 2000; 12: 4–14.
- 25 Mathew S, Murty VV, Hunziker W, Chaganti RS. Subregional mapping of 13 single-copy genes at the long arm of chromosome 12 by fluoresence in situ hybridization. Genomics 1992; 14: 775–9.
- 26 Motro B, Van Der Kooy D, Rossant J et al. Contiguous patterns of c-kit and steel expression: analysis of mutations at the W and Sl loci. Development 1991; 113: 1207–21.
- 27 Nishikawa S, Kusakabe M, Yoshinaga K et al. In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development. EMBO J 1991; 10: 2111–18.
- 28 Morrison-Graham K, Weston JA. Transient steel factor dependence by neural crest-derived melanocyte precursors. Dev Biol 1993; 159: 346–52.
- 29 Steel KP, Davidson DR, Jackson IJ. TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development 1992; 115: 1111–19.
- 30 Imokawa G, Yada Y, Kimura M. Signalling mechanisms of endothelin-induced mitogenesis and melanogenesis in human melanocytes. Biochem J 1996; 314 (Pt 1): 305–12.
- 31 Grichnik JM, Burch JA, Burchette J, Shea CR. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol 1998; 111: 233–8.
- 32 Hachiya A, Kobayashi A, Ohuchi A et al. The paracrine role of stem cell factor/c-kit signaling in the activation of human melanocytes in ultraviolet B-induced pigmentation. J Invest Dermatol 2001; 116: 578–86.
- 33 Hattori H, Kawashima M, Ichikawa Y, Imokawa G. The epidermal stem cell factor is over-expressed in lentigo senilis: implication for the mechanism of hyperpigmentation. J Invest Dermatol 2004; 122: 1256–65.
- 34 Shishido E, Kadono S, Manaka I et al. The mechanism of epidermal hyperpigmentation in dermatofibroma is associated with stem cell factor and hepatocyte growth factor expression. J Invest Dermatol 2001; 117: 627–33.
- 35 Kitamura R, Tsukamoto K, Harada K et al. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. J Pathol 2004; 202: 463–75.
- 36 Wu CS, Lan CC, Wang LF et al. Effects of PUVA irradiation on cultured epidermal cells in vitro and vitiligo patients in vivo. Br J Dermatol 2007; 156: 122–9.
- 37 Lan CC, Chen GS, Chiou MH et al. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Br J Dermatol 2005; 153: 498–505.
- 38 Kasamatus S, Hachiya A, Higuchi K et al. Production of the soluble form of KIT, s-KIT, abolishes stem cell factor-induced melanogenesis in human melanocytes. J Invest Dermatol 2008; 128: 1763–72.
- 39 Ezquerra M, Campdelacreu J, Muñoz E et al. A novel intronic mutation in the DDP1 gene in a family with X-linked dystonia-deafness syndrome. Arch Neurol 2005; 62: 306–8.
- 40 Müller JS, Stucka R, Neudecker S et al. An intronic base alteration of the CHRNE gene leading to a congenital myasthenic syndrome. Neurology 2005; 65: 463–5.
- 41 Hiraoka A, Yano K, Kagami N et al. Stem cell growth factor: in situ hybridization analysis on the gene expression, molecular characterization, and in vitro proliferative activity of a recombinant preparation on primitive hematopoietic progenitor cells. Hematol J 2001; 2: 307–15.
- 42 Gehling UM, Ergün S, Schumacher U et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106–12.
- 43 Hiraoka A, Sugimura A, Seki T et al. Cloning, expression, and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cells. Proc Natl Acad Sci U S A 1997; 94: 7577–82.
- 44 Mio H, Kagami N, Yokokawa S et al. Isolation and characterization of a cDNA for human mouse, and rat full-length stem cell growth factor, a new member of C-type lectin superfamily. Biochem Biophys Res Commun 1998; 249: 124–30.
- 45 Ito C, Sato H, Ando K et al. Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation. Bone Marrow Transplant 2003; 32: 391–8.
- 46 Tu C, Fu H, Lin X. Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo. J Dermatol Sci 1999; 21: 59–62.
- 47 Fain PR, Gowan K, LaBerge GS et al. A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Human Genet 2003; 72: 1560–4.
- 48 Taştan HB, Akar A, Orkunoğlu FE et al. Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 2004; 17: 181–4.
- 49 Fain PR, Babu SR, Bennett DC, Spritz RA. HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 2006; 19: 51–7.
- 50 Liu JB, Li M, Chen H et al. Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol 2007; 21: 205–13.
- 51 Canton I, Akhtar S, Gavalas NG et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phophatase (PTPN22) confers a susceptibility to generalized vitiligo. Genes Immuno 2005; 6: 584–7.
- 52 Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Clin Endocr Metab 1998; 83: 1049–55.
- 53 Spritz RA. The genetics of generalized vitiligo and associated autoimmune disease. Pigment Cell Res 2007; 20: 271–8.
- 54 LaBerge GS, Bennett DC, Fain PR, Spritz RA. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not. J Invest Dermatol 2008; 128: 1757–62.
- 55 Jin Y, Bennett DC, Amadi-Myers A et al. Vitiligo-associated multiple autoimmune disease is not associated with genetic variation in AIRE. Pigment Cell Res 2007; 20: 402–4.
- 56 Alkhateeb A, Stetler GL, Old W et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3–p32.2. Hum Mol Genet 2002; 11: 661–7.
- 57 Alkhateeb A, Fain PR, Spritz RA. Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo. J Invest Dermatol 2005; 125: 388–91.
- 58 Spritz RA, Gowan K, Bennett DC, Fain PR. Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004; 74: 188–91.
- 59 Nath SK, Kelly JA, Namjou B et al. Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001; 69: 1401–6.
- 60 Jin Y, Mailoux CM, Gowen K et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007; 356: 1216–25.
- 61 Jin Y, Birlea SA, Fain PR, Spritz RA. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 2007; 127: 2558–62.
- 62 Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4: 45–61.
